Cargando…
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
The use of immunosuppressive (IS) drugs to treat transplant recipients has markedly reduced the incidence of acute rejection and early graft loss. However, such treatments have numerous adverse side effects and fail to prevent chronic allograft dysfunction. In this context, therapies based on the ad...
Autores principales: | Moreau, Aurélie, Varey, Emilie, Bériou, Gaëlle, Hill, Marcelo, Bouchet-Delbos, Laurence, Segovia, Mercedes, Cuturi, Maria-Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414843/ https://www.ncbi.nlm.nih.gov/pubmed/22908013 http://dx.doi.org/10.3389/fimmu.2012.00218 |
Ejemplares similares
-
Cell therapy using tolerogenic dendritic cells in transplantation
por: Moreau, Aurélie, et al.
Publicado: (2012) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018) -
Evaluation of the Therapeutic Potential of Bone Marrow-Derived Myeloid Suppressor Cell (MDSC) Adoptive Transfer in Mouse Models of Autoimmunity and Allograft Rejection
por: Drujont, Lucile, et al.
Publicado: (2014) -
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020) -
Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset
por: Abidi, Ahmed, et al.
Publicado: (2020)